HLA
DERM

Hamilton Lane Advisors’s Dermira, Inc. DERM Stock Holding History

Hamilton Lane Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,615
Closed -$747K – 75
2016
Q4 		$747K Hold
24,615
– – 0.49% 42
2016
Q3 		$832K Sell
24,615
-10,000
-29% -$322K 0.42% 44
2016
Q2 		$1.1M Buy
34,615
+22,229
+179% +$613K 0.53% 35
2016
Q1 		$256K Buy
+12,386
New +$304K 0.12% 51

Other funds holding DERM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hamilton Lane Advisors's DERM Position: Q1 2017 in Review

Hamilton Lane Advisors sold out of Dermira, Inc. (DERM) in Q1 2017, closing a stake of 24,615 shares — an estimated $747K sold.

Hamilton Lane Advisors first reported a position in DERM in Q1 2016 and held it in 4 quarters. The position peaked at $1.1M in Q2 2016. 134 funds tracked by Wall St. Rank hold DERM as of Q1 2017.

  • Hamilton Lane Advisors reported no remaining Dermira, Inc. position as of Q1 2017 after selling out during the quarter.
  • Hamilton Lane Advisors sold 24,615 Dermira, Inc. shares in Q1 2017, an estimated $747K.
  • Hamilton Lane Advisors first reported a position in Dermira, Inc. in Q1 2016 and held it in 4 quarters.
  • Hamilton Lane Advisors's Dermira, Inc. position peaked at $1.1M in Q2 2016.
  • 134 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2017.

Based on Hamilton Lane Advisors's 13F filing for Q1 2017, filed 24 Apr 2017.